Provided by Tiger Trade Technology Pte. Ltd.

TELA Bio, Inc.

0.7461
+0.05608.11%
Post-market: 0.78810.0420+5.63%16:03 EDT
Volume:389.51K
Turnover:289.33K
Market Cap:33.22M
PE:-0.84
High:0.8220
Open:0.6700
Low:0.6700
Close:0.6901
52wk High:2.20
52wk Low:0.6200
Shares:44.53M
Float Shares:21.67M
Volume Ratio:1.34
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8852
EPS(LYR):-1.3265
ROE:-676.41%
ROA:-38.68%
PB:21.34
PE(LYR):-0.56

Loading ...

TELA Bio Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Nov 18, 2025

Strategic Initiatives and Financial Adjustments Underpin Buy Rating for TELA Bio Despite Short-term Challenges

TIPRANKS
·
Nov 18, 2025

Tela Bio price target lowered to $4 from $7 at Canaccord

TIPRANKS
·
Nov 18, 2025

EW Healthcare Partners Fund 2 Acquires Common Shares of TELA Bio Inc

Reuters
·
Nov 18, 2025

TELA Bio Grants Stock Options and Restricted Units to New Employees

Reuters
·
Nov 18, 2025

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 18, 2025

TELA Bio Secures $70 Million Term Loan Facility from Perceptive Credit Holdings

Reuters
·
Nov 15, 2025

TELA Bio Is Maintained at Market Outperform by Citizens

Dow Jones
·
Nov 14, 2025

Tela Bio price target lowered to $1.25 from $2 at Piper Sandler

TIPRANKS
·
Nov 14, 2025

Positive Sentiment Still Eludes TELA Bio, Inc. (NASDAQ:TELA) Following 26% Share Price Slump

Simply Wall St.
·
Nov 14, 2025

TELA Bio Reports Q3 Revenue Growth and New Credit Facility

TIPRANKS
·
Nov 14, 2025

Press Release: TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

Dow Jones
·
Nov 14, 2025

TELA Bio Inc. reports Q3 revenue of $20.7 million, up 9%

Reuters
·
Nov 14, 2025

TELA Bio Q3 Gross Profit USD 13.969 Million

THOMSON REUTERS
·
Nov 14, 2025

TELA Bio Inc - Full Year 2025 Revenue Is Projected to Grow at Least 16% Over 2024

THOMSON REUTERS
·
Nov 14, 2025

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

THOMSON REUTERS
·
Nov 14, 2025

TELA Bio Inc. to Release Third Quarter 2025 Financial Results

Reuters
·
Nov 04, 2025

TELA Bio Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

TELA Bio Inc. Files Initial Statement of Beneficial Ownership for Director William J. Plovanic

Reuters
·
Nov 04, 2025

TELA Bio Appoints William Plovanic to Board of Directors

GlobeNewswire
·
Nov 04, 2025